| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoclasts | 15 | 2025 | 32 | 3.760 |
Why?
|
| Receptors, Immunologic | 14 | 2024 | 72 | 2.900 |
Why?
|
| Adaptor Proteins, Signal Transducing | 12 | 2017 | 163 | 2.330 |
Why?
|
| Osteoarthritis | 3 | 2026 | 39 | 2.010 |
Why?
|
| Osteoporosis | 8 | 2019 | 63 | 2.000 |
Why?
|
| Bone Remodeling | 5 | 2025 | 14 | 1.970 |
Why?
|
| Membrane Glycoproteins | 10 | 2024 | 147 | 1.960 |
Why?
|
| Macrophages | 10 | 2024 | 302 | 1.530 |
Why?
|
| Bone Density Conservation Agents | 5 | 2019 | 18 | 1.510 |
Why?
|
| Bone Resorption | 8 | 2017 | 23 | 1.460 |
Why?
|
| Cytokines | 7 | 2025 | 448 | 1.260 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2022 | 134 | 1.200 |
Why?
|
| Bone and Bones | 4 | 2025 | 78 | 1.130 |
Why?
|
| Inflammation | 8 | 2026 | 642 | 1.130 |
Why?
|
| Glucocorticoids | 5 | 2019 | 115 | 1.100 |
Why?
|
| Synovitis | 2 | 2017 | 6 | 1.100 |
Why?
|
| Animals | 41 | 2026 | 10583 | 1.050 |
Why?
|
| Heart Failure | 4 | 2022 | 250 | 1.020 |
Why?
|
| Signal Transduction | 13 | 2024 | 1455 | 1.010 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2026 | 8 | 0.970 |
Why?
|
| Lipopolysaccharides | 4 | 2020 | 157 | 0.970 |
Why?
|
| Cell Differentiation | 11 | 2023 | 419 | 0.960 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 2 | 2024 | 22 | 0.950 |
Why?
|
| Osteoblasts | 5 | 2025 | 39 | 0.940 |
Why?
|
| Rheumatic Diseases | 2 | 2022 | 33 | 0.880 |
Why?
|
| Mice | 31 | 2025 | 4735 | 0.850 |
Why?
|
| Phagocytosis | 1 | 2024 | 80 | 0.830 |
Why?
|
| Microglia | 1 | 2024 | 68 | 0.810 |
Why?
|
| Adipose Tissue | 2 | 2025 | 186 | 0.810 |
Why?
|
| Megakaryocytes | 1 | 2023 | 30 | 0.790 |
Why?
|
| Bone Marrow | 1 | 2023 | 81 | 0.770 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 135 | 0.730 |
Why?
|
| Panniculitis | 1 | 2020 | 4 | 0.690 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2020 | 25 | 0.680 |
Why?
|
| Humans | 36 | 2026 | 28585 | 0.660 |
Why?
|
| Vagus Nerve Stimulation | 5 | 2022 | 76 | 0.650 |
Why?
|
| Adipocytes | 1 | 2020 | 58 | 0.650 |
Why?
|
| Interleukin-6 | 2 | 2020 | 194 | 0.640 |
Why?
|
| Bone Diseases | 2 | 2017 | 11 | 0.630 |
Why?
|
| Diphosphonates | 2 | 2018 | 15 | 0.630 |
Why?
|
| Fractures, Bone | 2 | 2018 | 46 | 0.610 |
Why?
|
| Osteogenesis | 3 | 2017 | 41 | 0.610 |
Why?
|
| Prednisone | 1 | 2018 | 53 | 0.590 |
Why?
|
| Immunity, Innate | 4 | 2017 | 231 | 0.580 |
Why?
|
| Quality of Life | 1 | 2022 | 504 | 0.550 |
Why?
|
| Complement Activation | 1 | 2017 | 27 | 0.550 |
Why?
|
| Cell Line | 9 | 2024 | 698 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 13 | 2025 | 1602 | 0.510 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 285 | 0.490 |
Why?
|
| Myxoma | 2 | 2012 | 6 | 0.470 |
Why?
|
| Paraneoplastic Syndromes | 2 | 2012 | 9 | 0.470 |
Why?
|
| Heart Neoplasms | 2 | 2012 | 17 | 0.470 |
Why?
|
| RANK Ligand | 5 | 2017 | 19 | 0.450 |
Why?
|
| Bone Density | 4 | 2018 | 101 | 0.440 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2017 | 44 | 0.430 |
Why?
|
| Mice, Knockout | 11 | 2024 | 862 | 0.410 |
Why?
|
| Transcription Factor 3 | 1 | 2012 | 2 | 0.400 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 95 | 0.390 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 3 | 2020 | 25 | 0.390 |
Why?
|
| Atrial Fibrillation | 4 | 2020 | 402 | 0.390 |
Why?
|
| Endotoxins | 1 | 2012 | 28 | 0.380 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 244 | 0.370 |
Why?
|
| Cell Membrane | 1 | 2013 | 259 | 0.360 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 173 | 0.350 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2022 | 247 | 0.330 |
Why?
|
| Bone Marrow Cells | 2 | 2023 | 81 | 0.330 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2010 | 48 | 0.320 |
Why?
|
| Estrogens | 2 | 2007 | 56 | 0.320 |
Why?
|
| Macrophage Activation | 2 | 2020 | 32 | 0.310 |
Why?
|
| Receptors, IgG | 2 | 2007 | 47 | 0.300 |
Why?
|
| Male | 20 | 2025 | 13772 | 0.300 |
Why?
|
| Phosphorylation | 4 | 2017 | 581 | 0.300 |
Why?
|
| Stroke Volume | 4 | 2022 | 124 | 0.290 |
Why?
|
| Female | 17 | 2024 | 15472 | 0.290 |
Why?
|
| Osteoporotic Fractures | 2 | 2017 | 5 | 0.270 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 3 | 2016 | 6 | 0.270 |
Why?
|
| Ovariectomy | 1 | 2007 | 53 | 0.270 |
Why?
|
| TRPC Cation Channels | 2 | 2020 | 34 | 0.260 |
Why?
|
| Ventricular Function, Left | 3 | 2022 | 112 | 0.250 |
Why?
|
| Biomarkers | 3 | 2020 | 770 | 0.250 |
Why?
|
| Chondrocytes | 1 | 2026 | 30 | 0.240 |
Why?
|
| Apoptosis | 2 | 2024 | 777 | 0.240 |
Why?
|
| Receptors, Fc | 3 | 2016 | 31 | 0.240 |
Why?
|
| Immune System | 1 | 2005 | 29 | 0.240 |
Why?
|
| Disease Progression | 2 | 2017 | 475 | 0.240 |
Why?
|
| Chemotaxis | 1 | 2005 | 28 | 0.240 |
Why?
|
| Kidney | 2 | 2024 | 286 | 0.230 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2005 | 83 | 0.230 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2017 | 72 | 0.230 |
Why?
|
| Physical Conditioning, Animal | 1 | 2025 | 38 | 0.220 |
Why?
|
| Diabetic Nephropathies | 1 | 2024 | 21 | 0.220 |
Why?
|
| Tibia | 2 | 2016 | 39 | 0.220 |
Why?
|
| Aged | 5 | 2022 | 5525 | 0.220 |
Why?
|
| Vagus Nerve | 3 | 2020 | 106 | 0.210 |
Why?
|
| Macrophage Colony-Stimulating Factor | 3 | 2017 | 9 | 0.210 |
Why?
|
| Lysosomes | 1 | 2024 | 56 | 0.210 |
Why?
|
| Amyloid beta-Peptides | 1 | 2024 | 49 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2011 | 285 | 0.210 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2016 | 301 | 0.210 |
Why?
|
| Hematopoiesis | 1 | 2023 | 25 | 0.200 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 137 | 0.200 |
Why?
|
| Cell Nucleus | 1 | 2003 | 138 | 0.200 |
Why?
|
| Cell Lineage | 1 | 2023 | 51 | 0.200 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2013 | 44 | 0.200 |
Why?
|
| Synovial Membrane | 2 | 2025 | 13 | 0.200 |
Why?
|
| Membrane Proteins | 2 | 2005 | 485 | 0.190 |
Why?
|
| Aging | 3 | 2016 | 979 | 0.190 |
Why?
|
| Hydroxychloroquine | 1 | 2022 | 20 | 0.190 |
Why?
|
| Monocytes | 1 | 2023 | 135 | 0.190 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2021 | 5 | 0.180 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 223 | 0.180 |
Why?
|
| Toll-Like Receptors | 3 | 2012 | 22 | 0.180 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 49 | 0.180 |
Why?
|
| Cilia | 1 | 2021 | 42 | 0.180 |
Why?
|
| 3T3-L1 Cells | 1 | 2020 | 30 | 0.170 |
Why?
|
| Protease Inhibitors | 1 | 2020 | 40 | 0.170 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 166 | 0.170 |
Why?
|
| Rheumatology | 2 | 2017 | 18 | 0.170 |
Why?
|
| Mitochondria | 1 | 2024 | 396 | 0.170 |
Why?
|
| Parathyroid Hormone | 1 | 2020 | 24 | 0.160 |
Why?
|
| Cohort Studies | 1 | 2022 | 893 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2022 | 458 | 0.160 |
Why?
|
| Polymyalgia Rheumatica | 1 | 2018 | 2 | 0.150 |
Why?
|
| Sex Characteristics | 2 | 2021 | 172 | 0.150 |
Why?
|
| Middle Aged | 6 | 2022 | 7310 | 0.150 |
Why?
|
| Risk Factors | 2 | 2017 | 2111 | 0.140 |
Why?
|
| Obesity | 1 | 2024 | 675 | 0.140 |
Why?
|
| Calcium | 2 | 2009 | 243 | 0.140 |
Why?
|
| Nuclear Proteins | 2 | 2011 | 249 | 0.140 |
Why?
|
| Genes, Regulator | 1 | 2017 | 11 | 0.140 |
Why?
|
| Ankylosis | 1 | 2017 | 3 | 0.140 |
Why?
|
| RAW 264.7 Cells | 1 | 2017 | 21 | 0.140 |
Why?
|
| Chemokines | 1 | 2017 | 74 | 0.140 |
Why?
|
| Models, Genetic | 1 | 2017 | 125 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 78 | 0.130 |
Why?
|
| Growth Inhibitors | 2 | 2009 | 11 | 0.130 |
Why?
|
| Antirheumatic Agents | 1 | 2017 | 57 | 0.130 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 63 | 0.130 |
Why?
|
| Rats, Inbred Dahl | 3 | 2022 | 16 | 0.130 |
Why?
|
| Genomics | 1 | 2017 | 123 | 0.130 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 25 | 0.130 |
Why?
|
| Immunomodulation | 1 | 2016 | 20 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2017 | 817 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2018 | 622 | 0.130 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2016 | 3 | 0.130 |
Why?
|
| Tibial Fractures | 1 | 2016 | 16 | 0.120 |
Why?
|
| Cochlea | 1 | 2016 | 20 | 0.120 |
Why?
|
| Hearing | 1 | 2016 | 28 | 0.120 |
Why?
|
| Hypertension | 1 | 2018 | 309 | 0.120 |
Why?
|
| Retrospective Studies | 1 | 2022 | 2612 | 0.120 |
Why?
|
| Enzyme Precursors | 2 | 2005 | 16 | 0.120 |
Why?
|
| Base Sequence | 4 | 2013 | 588 | 0.110 |
Why?
|
| Hip Joint | 1 | 2014 | 19 | 0.110 |
Why?
|
| Spine | 1 | 2015 | 62 | 0.110 |
Why?
|
| Osteoarthritis, Hip | 1 | 2014 | 12 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2005 | 97 | 0.110 |
Why?
|
| Protein Binding | 1 | 2016 | 664 | 0.110 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 1494 | 0.110 |
Why?
|
| Heart Atria | 2 | 2012 | 176 | 0.110 |
Why?
|
| Cartilage, Articular | 1 | 2014 | 44 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2017 | 1009 | 0.110 |
Why?
|
| Cell Division | 2 | 2013 | 154 | 0.110 |
Why?
|
| Multigene Family | 2 | 2003 | 51 | 0.110 |
Why?
|
| Gene Expression Regulation | 3 | 2010 | 633 | 0.100 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 58 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2012 | 267 | 0.100 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 1056 | 0.100 |
Why?
|
| Rats | 3 | 2022 | 1587 | 0.100 |
Why?
|
| Hydroxides | 1 | 2013 | 2 | 0.100 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2012 | 2 | 0.100 |
Why?
|
| Potassium Compounds | 1 | 2013 | 4 | 0.100 |
Why?
|
| Sodium Hydroxide | 1 | 2013 | 9 | 0.100 |
Why?
|
| Protein Transport | 1 | 2013 | 158 | 0.100 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2012 | 10 | 0.100 |
Why?
|
| NFATC Transcription Factors | 1 | 2012 | 14 | 0.100 |
Why?
|
| Retinitis | 1 | 2012 | 9 | 0.100 |
Why?
|
| Titanium | 1 | 2013 | 37 | 0.100 |
Why?
|
| SOS1 Protein | 1 | 2012 | 3 | 0.100 |
Why?
|
| 5'-Nucleotidase | 1 | 2012 | 13 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2017 | 631 | 0.090 |
Why?
|
| Ubiquitination | 1 | 2012 | 33 | 0.090 |
Why?
|
| Femur | 1 | 2012 | 22 | 0.090 |
Why?
|
| Ischemia | 1 | 2012 | 83 | 0.090 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1992 | 6 | 0.090 |
Why?
|
| Adenosine | 1 | 2012 | 33 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 148 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2012 | 188 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2011 | 550 | 0.090 |
Why?
|
| Amino Acid Sequence | 3 | 2005 | 695 | 0.090 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2010 | 3 | 0.090 |
Why?
|
| Bone Matrix | 1 | 2010 | 4 | 0.080 |
Why?
|
| Bone Conduction | 1 | 2010 | 8 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 59 | 0.080 |
Why?
|
| X-Ray Microtomography | 3 | 2016 | 32 | 0.080 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2010 | 6 | 0.080 |
Why?
|
| src Homology Domains | 1 | 2010 | 31 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 79 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 117 | 0.080 |
Why?
|
| DNA Primers | 2 | 2013 | 147 | 0.080 |
Why?
|
| Malnutrition | 1 | 2009 | 31 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 75 | 0.080 |
Why?
|
| Vitamin D Deficiency | 1 | 2009 | 31 | 0.080 |
Why?
|
| Retina | 1 | 2012 | 437 | 0.070 |
Why?
|
| Syk Kinase | 2 | 2005 | 12 | 0.070 |
Why?
|
| Interleukin-10 | 1 | 2009 | 74 | 0.070 |
Why?
|
| Lupus Nephritis | 1 | 2009 | 102 | 0.070 |
Why?
|
| Mass Screening | 1 | 2009 | 156 | 0.070 |
Why?
|
| Salmonella typhimurium | 1 | 2008 | 69 | 0.070 |
Why?
|
| Organ Size | 1 | 2007 | 88 | 0.070 |
Why?
|
| Uterus | 1 | 2007 | 31 | 0.070 |
Why?
|
| Vitamin D | 2 | 2017 | 51 | 0.070 |
Why?
|
| Radiography | 1 | 2007 | 203 | 0.060 |
Why?
|
| Lumbar Vertebrae | 1 | 2007 | 129 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2020 | 394 | 0.060 |
Why?
|
| Phenotype | 2 | 2022 | 682 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 253 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2005 | 64 | 0.060 |
Why?
|
| RNA Interference | 1 | 2005 | 137 | 0.060 |
Why?
|
| Synovial Fluid | 1 | 2025 | 12 | 0.060 |
Why?
|
| Integrin beta Chains | 1 | 2004 | 2 | 0.060 |
Why?
|
| Dendritic Cells | 1 | 2005 | 142 | 0.050 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2004 | 31 | 0.050 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2003 | 4 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2005 | 252 | 0.050 |
Why?
|
| Antigens, Surface | 1 | 2003 | 39 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 133 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 333 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 992 | 0.050 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2023 | 7 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2023 | 11 | 0.050 |
Why?
|
| Genome-Wide Association Study | 2 | 2017 | 233 | 0.050 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2022 | 4 | 0.050 |
Why?
|
| Fibrosis | 1 | 2022 | 134 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 128 | 0.040 |
Why?
|
| United States | 2 | 2017 | 2201 | 0.040 |
Why?
|
| Parathyroid Glands | 1 | 2020 | 7 | 0.040 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2011 | 24 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 2020 | 13 | 0.040 |
Why?
|
| Ear, External | 1 | 2020 | 13 | 0.040 |
Why?
|
| Time Factors | 2 | 2015 | 1600 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2020 | 72 | 0.040 |
Why?
|
| Haplotypes | 2 | 2011 | 284 | 0.040 |
Why?
|
| Incidence | 1 | 2021 | 568 | 0.040 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2018 | 12 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 1019 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 421 | 0.040 |
Why?
|
| Ligands | 2 | 2011 | 178 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 208 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2018 | 139 | 0.040 |
Why?
|
| Causality | 1 | 2017 | 13 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 25 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2017 | 22 | 0.030 |
Why?
|
| Teriparatide | 1 | 2017 | 1 | 0.030 |
Why?
|
| Denosumab | 1 | 2017 | 2 | 0.030 |
Why?
|
| Calcium, Dietary | 1 | 2017 | 11 | 0.030 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2017 | 8 | 0.030 |
Why?
|
| Thoracic Surgery | 1 | 2017 | 14 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 554 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2013 | 667 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2017 | 59 | 0.030 |
Why?
|
| Consensus | 1 | 2017 | 75 | 0.030 |
Why?
|
| Colitis | 1 | 2017 | 54 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 134 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 93 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 198 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2011 | 490 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2011 | 515 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 197 | 0.030 |
Why?
|
| Transcriptome | 1 | 2017 | 214 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 92 | 0.030 |
Why?
|
| Receptor, Insulin | 1 | 2015 | 93 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 671 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 509 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 1272 | 0.030 |
Why?
|
| Adult | 2 | 2017 | 7922 | 0.030 |
Why?
|
| Codon | 1 | 2013 | 22 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2014 | 152 | 0.030 |
Why?
|
| Wettability | 1 | 2013 | 3 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 111 | 0.020 |
Why?
|
| Solutions | 1 | 2013 | 31 | 0.020 |
Why?
|
| Calcium Phosphates | 1 | 2013 | 11 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2012 | 14 | 0.020 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2013 | 12 | 0.020 |
Why?
|
| Nanotubes | 1 | 2013 | 15 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2013 | 41 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 73 | 0.020 |
Why?
|
| Nanofibers | 1 | 2013 | 23 | 0.020 |
Why?
|
| Surface Properties | 1 | 2013 | 134 | 0.020 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2012 | 1 | 0.020 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2012 | 2 | 0.020 |
Why?
|
| Integrin-Binding Sialoprotein | 1 | 2012 | 2 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2013 | 139 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2012 | 9 | 0.020 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2012 | 4 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2012 | 8 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2012 | 46 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2012 | 53 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 1992 | 17 | 0.020 |
Why?
|
| Exons | 1 | 1992 | 42 | 0.020 |
Why?
|
| Retinal Vessels | 1 | 2012 | 75 | 0.020 |
Why?
|
| Temperature | 1 | 2013 | 213 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 179 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1992 | 77 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 319 | 0.020 |
Why?
|
| Remission Induction | 1 | 2011 | 58 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1992 | 257 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2011 | 43 | 0.020 |
Why?
|
| Binding Sites | 1 | 1992 | 354 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 55 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 461 | 0.020 |
Why?
|
| Cell Movement | 1 | 2012 | 373 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 108 | 0.020 |
Why?
|
| Cleidocranial Dysplasia | 1 | 2010 | 2 | 0.020 |
Why?
|
| Bone Development | 1 | 2010 | 6 | 0.020 |
Why?
|
| Elastic Modulus | 1 | 2010 | 23 | 0.020 |
Why?
|
| DNA | 1 | 1992 | 375 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 291 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2011 | 127 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2009 | 11 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2045 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 478 | 0.020 |
Why?
|
| Cecum | 1 | 2008 | 14 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2008 | 55 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 404 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 523 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2008 | 166 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 292 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2004 | 1 | 0.010 |
Why?
|
| Integrin beta3 | 1 | 2004 | 7 | 0.010 |
Why?
|
| Cathepsins | 1 | 2004 | 4 | 0.010 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2004 | 10 | 0.010 |
Why?
|
| Receptors, Calcitonin | 1 | 2004 | 8 | 0.010 |
Why?
|
| Osteopetrosis | 1 | 2004 | 1 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2004 | 55 | 0.010 |
Why?
|
| Leukemia P388 | 1 | 2003 | 3 | 0.010 |
Why?
|
| Protein Phosphatase 1 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2003 | 14 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2003 | 34 | 0.010 |
Why?
|
| Myeloid Cells | 1 | 2003 | 27 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2003 | 38 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 284 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 417 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 864 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2003 | 1341 | 0.010 |
Why?
|